Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

Bullboard (TSXV:TLT)

View:
Comment by Dumbeldorfwhiteon Nov 26, 2024 6:48pm

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Report on sedar

No idea where you re going with that. Another weirdo poster.
Comment by Dumbeldorfwhiteon Nov 26, 2024 6:46pm

RE:DUMBLES

Didn't say it was bad, I agree it's good. I'm simply asking why are we on boarding another clinical site when the banner literally on the top of the site says enroll complete by end of ...more  
Comment by CAinPlapon Nov 26, 2024 6:07pm

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Report on sedar

So you obviously know and likely are Michael.  Spiteful, vindictive and bitter? Looks good on ya. lol
Post by ramrodretiredon Nov 26, 2024 5:56pm

DUMBLES

Is very considered that a world class SURGON Boddy would agree to have a trial in his hospital! VERY GOOD SIGN Im sure he will reply, let see how long it takes .
Comment by Alamir1111on Nov 26, 2024 5:56pm

RE:RE:RE:RE:Dumbles agenda is odd makes no sense.

Funny myself got the ruler treatment .worst was cause couldn't complain much specially parents  if they found out I misbehaved  then got another spanking at home too.
Comment by Legit62on Nov 26, 2024 4:48pm

RE:RE:RE:Dumbles agenda is odd makes no sense.

The good ole days when boys were boys, got the wrist rulered a few times myself. Learned from it. Anyone think by Friday we here some positive news?? Almost into last month of quarter 4, suppose to be ...more  
Comment by Infinityon Nov 26, 2024 4:43pm

RE:RE:RE:Dumbles agenda is odd makes no sense.

Looks like the Dumble Dwarf fell off the wagon and on a Binge today.
Comment by gebremeskelon Nov 26, 2024 4:37pm

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Report on sedar

He might well be MB. I doubt he wants to be ignored. He's posts all that negative shyte for attention. I am loath to comply with his wishes. But rather than put him on ignore I just don't read ...more  
Comment by Dumbeldorfwhiteon Nov 26, 2024 4:25pm

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Report on sedar

The way you pump this stock my guess would be your initials are KH, RD, or Bencro. 
Comment by Galaxym31on Nov 26, 2024 3:59pm

RE:RE:Dumbles agenda is odd makes no sense.

Bad boy so bad into the corner. When I was in pre grade one I made my young class mates laugh as we sat on our little chairs in a circle . The teache  would have none of this so I was banished ...more  
Comment by CAinPlapon Nov 26, 2024 3:55pm

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Report on sedar

Guessing his intials may be MB. He actually wants folks to ignore him so his FUD campaign will go on unchallenged.
Comment by DJDawgon Nov 26, 2024 3:43pm

RE:RE:Dumbles agenda is odd makes no sense.

Please stop this thread. This board is mean for thoughtful discussion about TLT.
Comment by Dumbeldorfwhiteon Nov 26, 2024 3:38pm

RE:Dumbles agenda is odd makes no sense.

Your obsession with me is beyond weird , placing on ignore byeeeee
Comment by Dumbeldorfwhiteon Nov 26, 2024 3:36pm

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Report on sedar

Hahahahahahah this is coming from the guy who read 17 pages of someone's posts #genZ #stalking just use the ignore button
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250